Gelnique Approved for Overactive Bladder

Font Size

WEDNESDAY, Jan. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Watson Pharmaceuticals' Gelnique (oxybutynin chloride) to treat symptoms of overactive bladder, the company said in a news release.

Latest Medications News

Gelnique is a topical gel that's applied daily to the thigh, abdomen, upper arm or shoulder. Since it's absorbed through the skin, it's not metabolized by the liver as it would be were the drug's active ingredient, oxybutynin, taken orally, Watson said.

The most frequent side effects reported during clinical testing included dry mouth and reactions where the gel was applied.

Overactive bladder, with symptoms including incontinence, urgency and waking up at night to urinate, affects as many as 33 million adults in the United States, the company said.

-- Scott Roberts

News Articles
1
2
3
4
5
Next Article: Newer Blood Thinners May Outperform Old Standbys »

Printer-Friendly Format

Email to a Friend

Health categories:	Slideshows \| Diseases & Conditions \| Symptoms & Signs \| Procedures & Tests \| Medications \| Health & Living \| News & Views \| Medical Dictionary
Popular health centers:	Allergies \| Arthritis \| Cancer \| Diabetes \| Digestion \| Healthy Kids \| Heart \| Men's Health \| Mental Health \| Women's Health \| More...
Publications:	ePublications (PDFs) \| XML News via RSS \| Audio Podcasts \| Email Newsletters
MedicineNet.com:	About Us \| Privacy Policy \| Site Map \| WebMD® \| Medscape® \| eMedicine® \| eMedicineHealth® \| RxList®